GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Indo Global Exchange(s) Pte Ltd (OTCPK:IGEX) » Definitions » EV-to-Revenue

Indo Global Exchange(s) Pte (Indo Global Exchange(s) Pte) EV-to-Revenue : 1,045.67 (As of May. 22, 2024)


View and export this data going back to 2009. Start your Free Trial

What is Indo Global Exchange(s) Pte EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Indo Global Exchange(s) Pte's enterprise value is $3.14 Mil. Indo Global Exchange(s) Pte's Revenue for the trailing twelve months (TTM) ended in Oct. 2017 was $0.00 Mil. Therefore, Indo Global Exchange(s) Pte's EV-to-Revenue for today is 1,045.67.

The historical rank and industry rank for Indo Global Exchange(s) Pte's EV-to-Revenue or its related term are showing as below:

IGEX' s EV-to-Revenue Range Over the Past 10 Years
Min: 0   Med: 0   Max: 0
Current: 1045.67

IGEX's EV-to-Revenue is not ranked
in the Drug Manufacturers industry.
Industry Median: 2.335 vs IGEX: 1045.67

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-22), Indo Global Exchange(s) Pte's stock price is $0.0006. Indo Global Exchange(s) Pte's Revenue per Share for the trailing twelve months (TTM) ended in Oct. 2017 was $0.00. Therefore, Indo Global Exchange(s) Pte's PS Ratio for today is .


Indo Global Exchange(s) Pte EV-to-Revenue Historical Data

The historical data trend for Indo Global Exchange(s) Pte's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Indo Global Exchange(s) Pte EV-to-Revenue Chart

Indo Global Exchange(s) Pte Annual Data
Trend Jul08 Jul09 Jul10 Jul11 Jul12 Jul13 Jul14 Jul15 Jul16 Jul17
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 47.66 - - -

Indo Global Exchange(s) Pte Quarterly Data
Jan13 Apr13 Jul13 Oct13 Jan14 Apr14 Jul14 Oct14 Jan15 Apr15 Jul15 Oct15 Jan16 Apr16 Jul16 Oct16 Jan17 Apr17 Jul17 Oct17
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Indo Global Exchange(s) Pte's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Indo Global Exchange(s) Pte's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Indo Global Exchange(s) Pte's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Indo Global Exchange(s) Pte's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Indo Global Exchange(s) Pte's EV-to-Revenue falls into.



Indo Global Exchange(s) Pte EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Indo Global Exchange(s) Pte's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=3.137/0.003
=1,045.67

Indo Global Exchange(s) Pte's current Enterprise Value is $3.14 Mil.
Indo Global Exchange(s) Pte's Revenue for the trailing twelve months (TTM) ended in Oct. 2017 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Indo Global Exchange(s) Pte  (OTCPK:IGEX) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Indo Global Exchange(s) Pte's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=0.0006/0
=

Indo Global Exchange(s) Pte's share price for today is $0.0006.
Indo Global Exchange(s) Pte's Revenue per Share for the trailing twelve months (TTM) ended in Oct. 2017 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Indo Global Exchange(s) Pte EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Indo Global Exchange(s) Pte's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Indo Global Exchange(s) Pte (Indo Global Exchange(s) Pte) Business Description

Traded in Other Exchanges
N/A
Address
6400 S. Fiddlers Green, No. 250 No.1012, Greenwood Village, CO, USA, 80111
Indo Global Exchange(s) Pte Ltd is a holding company. The company is focusing on developing assets within the pharmaceutical and nutraceutical industries.